These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7006943)

  • 1. Hemoglobin A1c levels in children and adolescents with diabetes mellitus.
    Goldstein DE; Walker B; Rawlings SS; Hess RL; England JD; Peth SB; Hewett JE
    Diabetes Care; 1980; 3(4):503-7. PubMed ID: 7006943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glycosylated hemoglobin HbA1c as an indicator of metabolic compensation in children with diabetes mellitus].
    Michalková D; Carský J; Bircák J; Kolár J; Baciaková L; Vitková M; Zmeková E
    Cesk Pediatr; 1981 May; 36(5):243-7. PubMed ID: 7261146
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemoglobin A1c (HbA1c) in children with long standing and newly diagnosed diabetes mellitus.
    Heinze E; Kohne E; Meissner C; Beischer W; Teller WM; Kleihauer E
    Acta Paediatr Scand; 1979 Jul; 68(4):609-12. PubMed ID: 463544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group.
    J Clin Endocrinol Metab; 1987 Jul; 65(1):30-6. PubMed ID: 2884229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemoglobin A1c: a predictor for the duration of the remission phase in juvenile insulin-dependent diabetic patients.
    Vetter U; Heinze E; Beischer W; Kohne E; Kleihauer E; Teller WM
    Acta Paediatr Scand; 1980 Jul; 69(4):481-3. PubMed ID: 7004058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hemoglobin A1c and insulin C-peptide in anomalies of carbohydrate metabolism.
    Perier C; Hivert M; Frey J; Rousset H; Janin J
    Biomedicine; 1980 Nov; 33(7):232-6. PubMed ID: 7013838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin a1c values in children with overt diabetes maintained in varying degrees of control.
    Jackson RL; Hess RL; England JD
    Diabetes Care; 1979; 2(5):391-5. PubMed ID: 510136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fasting glycosylated hemoglobin A1c and behavior of blood sugar and blood insulin after oral glucose tolerance test in subjects with a family history of diabetes].
    Ferrero E; Casale G; Ricci C; Ravecca D
    Minerva Med; 1981 May; 72(20):1289-94. PubMed ID: 7017475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hemoglobin A1c and hemoglobin A1 in diabetic patients.
    James TM; Davis JE; McDonald JM; Santiago JV; Ladenson JH
    Clin Biochem; 1981 Feb; 14(1):25-7. PubMed ID: 7237739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes.
    Olsen B; Johannesen J; Fredheim S; Svensson J;
    Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relationship of glycosylated haemoglobin concentrations to glucose control in diabetics.
    Dunn PJ; Cole RA; Soeldner JS; Gleason RE; Kwa E; Firoozabadi H; Younger D; Graham CA
    Diabetologia; 1979 Oct; 17(4):213-20. PubMed ID: 499681
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic control in 102 insulin-treated out-patients.
    Tchobroutsky G; Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J
    Diabetologia; 1980 Jun; 18(6):447-52. PubMed ID: 6998808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of insulin glargine in children and adolescents with type 1 diabetes.
    Tan CY; Wilson DM; Buckingham B
    Pediatr Diabetes; 2004 Jun; 5(2):80-6. PubMed ID: 15189493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
    Giordano C; Pantŏ F; Amato MP; Sapienza N; Pugliese A; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):611-7. PubMed ID: 2252529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus.
    Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G
    Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minor hemoglobins in insulin-dependent childhood diabetes mellitus].
    Luppis B; Beccaria L; Meschi F; di Natale B; Chiumello G
    Minerva Dietol Gastroenterol; 1979; 25(3):335-8. PubMed ID: 554022
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycosylated hemoglobin and canine diabetes mellitus.
    Wood PA; Smith JE
    J Am Vet Med Assoc; 1980 Jun; 176(11):1267-8. PubMed ID: 7429925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.
    Dahlquist G; Blom L; Bolme P; Hagenfeldt L; Lindgren F; Persson B; Thalme B; Theorell M; Westin S
    Diabetes Care; 1982; 5(4):399-403. PubMed ID: 6759078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.